Literature DB >> 9732377

Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers.

S Pierno1, A De Luca, C Camerino, R J Huxtable, D C Camerino.   

Abstract

A reduction of resting chloride conductance (GCl) and a decrease of the voltage threshold for contraction are observed during aging in rat skeletal muscle. The above alterations are also observed in muscle of adult rat after taurine depletion. As lower levels of taurine were found by others in aged rats compared to young rats, we tested the hypothesis that a depletion of taurine may contribute to the alteration of the electrical and contractile properties we found in skeletal muscle during aging. This was accomplished by evaluating the potential benefit of a pharmacological treatment with the amino acid. To this aim 25-mo-old Wistar rats were chronically treated (2-3 mo) with taurine (1 g/kg p.o. daily) and the effects of such a treatment were evaluated in vitro on the passive and active membrane electrical properties of extensor digitorum longus muscle fibers by means of current-clamp intracellular microelectrode technique. Excitation-contraction coupling was also evaluated by measuring the voltage threshold for contraction with the intracellular microelectrode "point" voltage clamp method. In parallel muscle and blood taurine contents were determined by high-performance liquid chromatography. Taurine supplementation significantly raised taurine content in muscle toward that found in adult rats. Supplementation also significantly increased GCl vs. the adult value, in parallel the excitability characteristics (threshold current and latency) related to this parameter were ameliorated. The increase of GCl induced by taurine was accompanied by a restoration of the pharmacological sensitivity to the R(+) enantiomer of 2-(p-chlorophenoxy) propionic acid, a specific chloride channel ligand. In parallel also the protein kinase C-mediated modulation of the channel was restored; in fact the potency of 4-beta-phorbol 12, 13-dibutyrate in reducing GCl was lower in taurine-treated muscles vs. untreated aged, being rather similar to that observed in adult. The treatment also improved the mechanical threshold for contraction of striated fibers which in aged rats is shifted toward more negative potentials, moving it toward the adult values. Our results suggest that the reduction of taurine content could play a role in the alteration of electrical and contractile properties observed during aging. These findings may indicate a potential application of taurine in ensuring normal muscle function in the elderly.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732377

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine.

Authors:  A De Luca; S Pierno; A Liantonio; M Cetrone; C Camerino; S Simonetti; F Papadia; D C Camerino
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

2.  Effects of long-term taurine supplementation on age-related changes in skeletal muscle function of Sprague-Dawley rats.

Authors:  Yun Ma; Hitomi Maruta; Baojun Sun; Chengduo Wang; Chiaki Isono; Hiromi Yamashita
Journal:  Amino Acids       Date:  2021-01-04       Impact factor: 3.520

3.  Effect of taurine on sarcoplasmic reticulum function and force in skinned fast-twitch skeletal muscle fibres of the rat.

Authors:  Anthony J Bakker; Helen M Berg
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

4.  Taurine blocks ATP-sensitive potassium channels of rat skeletal muscle fibres interfering with the sulphonylurea receptor.

Authors:  D Tricarico; M Barbieri; D C Camerino
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

5.  An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function.

Authors:  Sabata Pierno; Domenico Tricarico; Antonella Liantonio; Antonietta Mele; Claudio Digennaro; Jean-François Rolland; Gianpatrizio Bianco; Luciano Villanova; Alessandro Merendino; Giulia Maria Camerino; Annamaria De Luca; Jean-François Desaphy; Diana Conte Camerino
Journal:  Age (Dordr)       Date:  2013-05-30

6.  Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor.

Authors:  Sabata Pierno; Annamaria De Luca; Jean-François Desaphy; Bodvael Fraysse; Antonella Liantonio; Maria Paola Didonna; Marcello Lograno; Daniela Cocchi; Roy G Smith; Diana Conte Camerino
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

7.  Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulation.

Authors:  Craig A Goodman; Deanna Horvath; Christos Stathis; Trevor Mori; Kevin Croft; Robyn M Murphy; Alan Hayes
Journal:  J Appl Physiol (1985)       Date:  2009-05-07

8.  Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ.

Authors:  Giulia Maria Camerino; Marina Bouchè; Michela De Bellis; Maria Cannone; Antonella Liantonio; Kejla Musaraj; Rossella Romano; Piera Smeriglio; Luca Madaro; Arcangela Giustino; Annamaria De Luca; Jean-François Desaphy; Diana Conte Camerino; Sabata Pierno
Journal:  Pflugers Arch       Date:  2014-03-20       Impact factor: 3.657

9.  Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.

Authors:  A Liantonio; V Giannuzzi; A Picollo; E Babini; M Pusch; D Conte Camerino
Journal:  Br J Pharmacol       Date:  2006-11-27       Impact factor: 8.739

Review 10.  Taurine and skeletal muscle disorders.

Authors:  Diana Conte Camerino; Domenico Tricarico; Sabata Pierno; Jean-François Desaphy; Antonella Liantonio; Michael Pusch; Rosa Burdi; Claudia Camerino; Bodvael Fraysse; Annamaria De Luca
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.